Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (6): 104-108    DOI:
REVIEWS     
Gene Strategies of Enhancing the Anti-apoptosis Ability of Mammalian Cell in Engineering
XU Hong-ji, ZHANG Bing-bing
Bioengineering College, Chongqing University, Chongqing 400030, China) (Key Laboratory of Biorheological Science and Technology, Chongqing University, Ministry of Education, Chongqing 400030, China
Download: HTML   PDF(357KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Mammalian cells have significant advantages in producing recombinant protein drugs, which make it widely used in industry. In the process of production, however, environmental stress, which can result from nutrient depletion and by-product accumulation, activates apoptosis through signalling cascades regulators. It is the burden of improving the protein production that have the cell more susceptible to apoptosis, decreasing bioreactor performance and hindering large-scale production. Therefore,apoptosis, programed cell death, seriously limits the recombinant protein production, and how to improve the anti-apoptotic ability of engineering cells has accordingly become a hot point that attracted the attention of biologists all over the world. Apoptosis, as well as proliferation and differentiation, is one of the biological processes that cell must experience. With the understanding of the mechanism of apoptosis and revealing of many apoptosis genes in previous studies, a variety of anti-apoptotic approaches were found which is helpful to inhibit apoptosis and to enhance the robustness, survival and productivity of production cell lines. The anti-apoptotic approaches commonly used in engineering include: lowering apoptotic proteins, increasing anti-apoptotic proteins, over-expressing growth factor and insuin-like growth factor and modifying the intracellular enzyme related to metabolism in order to prevent the toxic metabolites from accumulating. Although the resistance of cell to apoptosis were, to some extent, improved by the strategies mentioned above, it is very essential for biotechnologists to search for more effective anti-apoptotic approaches that could lead to the greatest improvements in cell survival, provide unequalled bioreactor performance and enhance biopharmaceutical productivities.

Key wordsCell engineering      Anti-apoptosis      Mammalian cell     
Received: 28 March 2012      Published: 25 June 2012
ZTFLH:  Q819  
Cite this article:

XU Hong-ji, ZHANG Bing-bing. Gene Strategies of Enhancing the Anti-apoptosis Ability of Mammalian Cell in Engineering. China Biotechnology, 2012, 32(6): 104-108.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I6/104

[1] Walsh G. Biopharmaceutical benchmarks 2010. Nature Biotechnology,2010,28(9):917-924.
[2] Krampe B,Al-Rubeai M. Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies. Cytotechnology,2010,62(2010):175-188.
[3] Liew J C,Tan W S,Mohamed Alitheen N B,et al.Over-expression of the X-linked inhibitor of apoptosis protein (XIAP) delays serum deprivation-induced apoptosis in CHO-K1 cells.Journal of Bioscience and Bioengi -neering,2010,110 (3):338-344.
[4] Sauerwald T M,Oyler G A,Betenbaugh M J. Study of caspase inhibitors for limiting death in mammalian cell culture.Biotechnology and Bioengineering,2003,81(3):329-340.
[5] 来大志. CHO表达系统的遗传改造.北京:北京微生物流行病研究所,2003. Lai D Z. Genetic modification of the CHO expression system.Beijing:Beijing Institute of Microbiology Epidemiology,2003.
[6] Sung Y H,Hwang S J,Lee G M. Infuence of downregulation of caspase-3 by siRNAs on sodium-butyrate- induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin.Metabolic Engineering,2005,7(5-6):457-666.
[7] Sung Y H,Lee J S,Park S H, et al. Influence of co-down-regulation of caspase-3 and caspase-7 by siRNAs on sodium butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin.Meta -bolic Engineering,2007,9(5-6):452-464.
[8] Tey B T,Singh R P,Piredda L,et al.Bcl-2 mediated suppression of apoptosis in myeloma NS0 culture. Journal of Biotechnology,2000,79:147-159.
[9] Kim N S,Lee G M. Overexpression of bcl-2 inhibits sodium butyrate-induced apoptosis in Chinese Hamster Ovary cells resulting in enhanced humanized antibody production. Biotechnology and Bioengineering,2001,71(3):184-193.
[10] Figueroa B,Sauerwald T M,Oyler G A,et al. A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures.Metabolic Engineering,2003,5:230-245.
[11] Chao D T,Linette G P,Boise L H,et al. Bcl-xL and Bcl-2 repress a common pathway of cell death. Journal of Experimental Medicine,1995,182(3):821-828.
[12] Lim S F,Chuan K H,Liu S,et al.RNAi suppression of Bax and Bak enhances viability in fed-batch culture of CHO cells.Metabolic Engineering,2006,8:509-522.
[13] Cost G J,Freyvert Y,Vaiadis A,et al. Bak and Bax deletion using zinc-finger nucleases yields apoptosis -resistant CHO cells. Biotechnology and Bioengineering,2009,105(2):330-340.
[14] Dietmair S,Nielsen L K,Timmins N E.Engineering a mammalian super producer.Journal of Chemical Tech -nology & Biotechnology,2011,86:905-914.
[15] Huang D C,Cory S,Strasser A. Bcl-2, Bcl-xL and adenovirus protein E1B-19kD are functionally equivale -nt in their ability to inhibit cell death.Oncogene,1997,14(4):405-414.
[16] Nivitchanyong T,Martinez A,Ishaque A,et al. Anti-apoptotic genes Aven and E1B-19K enhance performa -nce of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.Biotech -nology and Bioengineering,2007,98(4):825-841.
[17] Galluzzi L,Brenner C,Morselli E,et al. Viral control of mitochondrial apoptosis. PLos Pathogen,2008,4(5):1-16.
[18] Vives J,Juanola S,Cairo J J,et al.Protective effect of viral homologues of Bcl-2 on Hybridoma cells under apoptosis-inducing conditions.Biotechnology Progress,2003,19(1):84-89.
[19] Jung D,Cote S,Drouin M,et al. Inducible expression of Bcl-xL restricts apoptosis resistance to the antibod -y secretion phase in hybirdoma cultures. Biotechnology and Bioengineering,2002,79(2):180-187.
[20] Subramanian T,Tarodi B,Chinnadurai G. p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by ElB19K and BcI-2 proteins. Cell Growth & Differentiation,1995,6:131-137.
[21] Vives J,Juanola S,Cairo J J,et al. Metabolic engineering of apoptosis in cultured animal cells: implications for the biotechnology industry.Metabolic Engineering,2003,5:124-132.
[22] Dorai H,Kyung Y S,Ellis D,et al. Expression of anti-apoptosis genes alters lactate metabolism of Chinese hamster ovary cells in culture.Biotechnology and Bioengineering,2009,103(3):592-608.
[23] Bruno F J,Chen S L,Oyler G A,et al.Aven and Bcl-xL enhance protection against apoptosis for mammalia -n cells exposed to various culture conditions.Biotechnology and Bioengineering,2004,85(6):589-600.
[24] Sunstrom N S,Gay R D,Wong D C,et al.Insulin-like growth factor-I and transferrin mediate growth and survival of Chinese hamster ovary cells.Biotechnology Progress,2000,16:698-702.
[25] Suntrorn N A,Hunt S. Regulated autocrine growth of CHO cells.Cytotechnology,2000,34:39-46.
[26] Chen K,Liu Q,Xie L,et al.Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production.Biotechnology Bioengineering,2001,72(1):55-61.
[27] Jeong D W,Kim T S,Lee J W,et al. Blocking of acidosis-mediated apoptosis by a reduction of lactate dehydr -ogenase activity through antisensemRNA expression. Biochemical and Biophysical Research Communication, 2001,289(5):1141-1149.
[28] Jeong D W,Kim T S,Cho I T,et al. Modification of glycolysis affects cell sensitivity to apoptosis induced by oxidative stress and mediated by mitochondria. Biochemical and Biophysical Research Communications 200 4,313(4):984-991.
[29] Kim S H,Lee G M. Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin.Appl Microbiol Biotechnol,2007,74:152-159.
[30] Bebinton C R,Renner G,Thomson S,et al.High-Ievel expression of a recombinant antibody from myelom -a cell using a glutamine synthestase gene as an amplifiable selectable marker. Nature Biotechnology,1992,10: 169-175.
[31] 来大志,付玲,于长明,等.用于生产重组蛋白药物的抗凋亡CHO宿主细胞株的建立.生物工程学报,2003,19(3):323-326. Lai D Z,Fu L,Yu C M,et al.Construction of an anti-apoptosis CHO cell line for biopharmaceutical production.Chinese Journal of Biotechnology,2003,19(3):323-326.
[1] WANG Hui-lin,ZHOU Kai-qiang,ZHU Hong-yu,WANG Li-jing,YANG Zhong-fan,XU Ming-bo,CAO Rong-yue. Research Progress of Human Coagulation Factor VII and the Recombinant Expression Systems[J]. China Biotechnology, 2021, 41(2/3): 129-137.
[2] Yu-lei GUO,Liang TANG,Rui-qiang SUN,You LI,Yi-jun CHEN. High-Throughput Micro Bioreactor Development for Biopharmaceuticals[J]. China Biotechnology, 2018, 38(8): 69-75.
[3] Xin GAO,Pan-jian WEI,Zhuo-hong YAN,Ling YI,Xiao-jue WANG,Bin YANG,Hong-tao ZHANG. Cloning and Expression of Single Chain Antibody Against Human EGFR[J]. China Biotechnology, 2018, 38(5): 73-78.
[4] LI Guo-kun, GAO Xiang-dong, XU Chen. Advances on Mammalian Cell Expression System[J]. China Biotechnology, 2014, 34(1): 95-100.
[5] HUI Kai-yuan, GAO Xiang-dong, XU Chen. Recent Advances in Cell Engineering for Monoclonal Antibody Production[J]. China Biotechnology, 2012, 32(02): 90-95.
[6] DIAO Yong. Inducible Gene Expression of Mammalian via RNA-only Strategies[J]. China Biotechnology, 2011, 31(12): 120-125.
[7] YANG Hui, GUO Qi, ZHAO Chang-qi, ZHOU Jian-ping. Research Progress on Cell Engineering and Endophytes of Rare Plant Sinopodophyllum emodi(Wall.) Ying[J]. China Biotechnology, 2010, 30(11): 94-99.
[8] . Advance in Fed-Batch Mammalian Cell Culture[J]. China Biotechnology, 2008, 28(11): 104-109.
[9] . Recombinant baculoviruses as mammalian cell gene-delivery vectors: a review[J]. China Biotechnology, 2007, 27(1): 126-130.
[10] . High-throughput Sorting Methods for the Selection of Highly Productive Cell Lines Expressing Exogenous Gene[J]. China Biotechnology, 2006, 26(0): 186-190.